ResearcherUniversity of LiverpoolNo recent work listed

Adam Lister

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7965-9999; OpenAlex author ID A5102963379. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2011: 1 paper

Papers 1

Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. Co-author DOI 10.1186/1476-4598-10-37 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

B. Kevin Park · 1 shared paper, 2011 · strength 0.02
- Paper Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. DOI 10.1186/1476-4598-10-37 ↗
Taoufik Nedjadi · 1 shared paper, 2011 · strength 0.02
- Paper Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. DOI 10.1186/1476-4598-10-37 ↗
John P. Neoptolemos · 1 shared paper, 2011 · strength 0.02
- Paper Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. DOI 10.1186/1476-4598-10-37 ↗
Eithne Costello · 1 shared paper, 2011 · strength 0.02
- Paper Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. DOI 10.1186/1476-4598-10-37 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.